The Ministry of Health and Welfare said on the 15th that it will create a hotline to supply syringes steadily to hemodialysis Clinic / local doctor's office (1st tier) specializing in dialysis. The Korean Medical Association, the Korean Society of Nephrology, and syringe makers and importers will join together. The goal is to make sure dialysis treatment does not stop in the middle. The government explained that recently the war in the Middle East could make syringe supply and demand unstable. So, until the end of June, it decided to supply needed syringes first to Clinic / local doctor's office (1st tier)-level hemodialysis institutions, as long as market order is not harmed. If needed, it plans to increase supply more through extra discussion. Minister Jeong Eun-kyeong of the Ministry of Health and Welfare said this hotline is the minimum safety net for the supply system of essential medical products. The government also said it will keep communicating with the field in real time and make measures that fit raw material supply and the supply chain traits of each item.
원문 보기Why can one syringe stop the whole dialysis room?
If you only read the article, it is easy to think, 'Maybe syringes are a bit short,' and move on. But hemodialysis is a treatment that takes blood out of the body, filters it with a machine, and puts it back in, so if even one small disposable item is cut off, the whole flow can shake. Especially, syringes keep appearing in catheter management, anticoagulant medicine giving, cleaning, and finishing steps.
Dialysis patients usually need treatment 2~3 times a week, at fixed times. Even if it is delayed just once, waste and fluid can build up in the body, causing shortness of breath, and in serious cases it can become an emergency. So a syringe shortage is not just a simple stock problem. It is seen as a problem where the schedule of life-sustaining treatment gets shaken.
Still, syringes are not in exactly the same position as a bloodline tube or a dialyzer artificial kidney filter, which are items that make it impossible to even start a session if they are missing. The difference is this. A bloodline stops the session itself from being possible, while a syringe creates a bottleneck in the whole operation before, during, and after dialysis. So if stock feels unstable for only a few days, hospitals quickly go into emergency operation, like checking substitute standards, adjusting use priority, and rearranging schedules.
Dialysis is not an optional treatment that can be delayed. If the fixed cycle is missed, the risk grows right away.
Syringes are used across many steps before, during, and after dialysis, so if they are short, the whole operation can easily get tangled.
This is how a syringe is used in one hemodialysis session
A syringe is not a tool that is used once and finished. It is closer to a connecting part that links the start, middle, and end of dialysis.
Step 1: Prepare the access route
Before dialysis, the condition of the vascular access route must be checked, and for patients using a catheter, the solution inside the port must be removed or cleaned. A syringe is used from this first step.
Step 2: Handle the catheter and line
A syringe is also needed in the process of handling connection parts so blood can move safely. If a problem happens here, it directly affects infection control and safety.
Step 3: Give the anticoagulant
During dialysis, medicines like heparin are used so the blood does not clot inside the circuit, and the syringe is important here too. Simply put, it feels like adding lubricant so the machine does not stop.
Step 4: Care during treatment
During treatment, extra flushing, blood collection, or giving some medicines may be needed. So the syringe is not just a start button, but a tool used continuously while things are running.
Step 5: lock·flush after finishing
After dialysis ends, there is a lock·flush step to close and clean the catheter. If this finishing step is unstable, it can affect the next dialysis schedule and even the risk of infection.
How a Middle East war can shake dialysis rooms in Korea
When you first hear it, it can feel a bit far away. Why would a Middle East war lead to a syringe problem at a neighborhood dialysis Clinic / local doctor's office (1st tier) in Korea? But disposable medical supplies depend more deeply than expected on the petrochemical supply chain. Things like syringes, dialysis tubes, and IV fluid bags use a lot of plastic-based materials like PP, PVC, and PE, and the starting point of these materials is crude oil and naphtha.
According to research, it was reported that about 54% of the naphtha Korea imports passes through the Strait of Hormuz. So if sea transport in the Middle East becomes unstable, material volume, prices, shipping time, and insurance costs all get pressure at the same time. Even if finished products are not bought directly from the Middle East, if raw materials and intermediate goods are tied together globally, hospital stock in Korea can still be shaken.
This is not only a story for wartime. In the United States, when a hurricane hit a certain IV fluid factory, hospitals across the country had IV fluid shortages. The common point is the same. They are essential goods, but if production, raw materials, and logistics are concentrated in just a few places, an accident far away can spread into a very nearby treatment room problem.
Middle East conflict → Strait of Hormuz anxiety → pressure on naphtha and polymers → burden on syringe and tube production → shortage felt by domestic hospitals
So, more important than 'where was it made' is 'what raw materials and shipping routes does it go through.'
Which medical supplies are especially weak to supply shocks
| Item | Weak point | Replacement possibility | Speed of patient impact | |
|---|---|---|---|---|
| Syringe | Sensitive to plastic raw materials and distribution bottlenecks | Some replacement possible depending on the standard | Fast — overall operations get tangled | |
| Dialysis tube | (bloodline) | High dependence on dedicated disposable supplies | Low | Very fast — affects whether the session can happen at all |
| IV fluid bag | Risk of concentration in certain factories and raw materials | Limited depending on the situation | Fast — direct hit to hospitalization and emergency treatment | |
| Gloves | Strongly affected by raw material and logistics shocks | Relatively high | Medium — can switch to replacement brands |
In 2009 too, clinic-level facilities were the most common
If you look at the number of institutions included in the hemodialysis evaluation, you can understand why the government looked at Clinics first.
Why were clinic-level hemodialysis institutions protected first
This part may feel a little unfamiliar if you do not know Korean healthcare well. If the treatment is directly linked to life, do people usually get it mainly at big university hospitals? But in Korea, maintenance hemodialysis has a fairly large share handled by local dialysis specialty clinics. In HIRA data, in 2009 the number of institutions evaluated was also highest for clinics, at 313 places.
This means the government did not look only at the 'most vulnerable places.' It is closer to saying that it first aimed at the frontline that actually handles the most repeated treatments. Dialysis must continue 2~3 times a week, so a system where patients steadily get treatment at a clinic near home is important. If inventory here becomes unstable, it is not easy for patients to change hospitals, and if everyone rushes to big hospitals at once, the burden there also grows quickly.
Clinic-level facilities are not just in a 'supporting role' - they are close to being the backbone of hemodialysis in Korea.
So stabilizing syringe supply from clinic-level facilities first is efficient for preventing gaps in treatment overall.
Dialysis specialty clinics and large hospitals do different work
| Category | Dialysis specialty clinic | Tertiary general hospital (3rd tier) |
|---|---|---|
| Main role | Repeated outpatient maintenance dialysis | Treatment for severe cases, complications, and hospitalized patients |
| Accessibility | Easy to use local care near home | Referral, waiting, and distance burdens are relatively larger |
| Response to infection and complications | Focused on basic management | Strong in complex infection control and multidisciplinary collaborative care |
| Transplant connection | Limited | Relatively strong |
| Impact when supply is disrupted | Local patient schedules are affected right away | Burden of accepting severe patients increases |
National essential medicines increased quickly
If you look at how much the number of items the government decided were 'hard to leave only to the market' increased, you can see the trend.
Who handles what: from the Ministry of Food and Drug Safety to the Korea Disease Control and Prevention Agency
| Agency | What it does | How it connects to this article |
|---|---|---|
| Ministry of Food and Drug Safety | Designation of national essential medicines, permit and supply checks, operation of working-level consultative group | The main axis that institutionally manages items with unstable supply |
| Ministry of Health and Welfare | Policy coordination, field consultation, public-private cooperation | Led the setup of this syringe hotline |
| Korea Disease Control and Prevention Agency | Stockpiling vaccine and infectious disease response supplies, operation of emergency transport system | Handles fast distribution and stockpiling systems in crises |
| Korea Orphan and Essential Drug Center | Supply of essential medicines that are hard to procure domestically | Helps prevent disruption even when marketability is low |
The hotline did not appear out of nowhere
This measure is not really an idea that suddenly appeared overnight. It is built on years of shortage experience.
2020: COVID made the supply chain a national issue
After going through the experience of procuring public masks and syringes for vaccines, the Korean government learned that it is hard to leave medical supplies only to the free market.
2022: Public-private talks on medicine shortages begin in earnest
The Ministry of Health and Welfare ran a public-private response group to improve medicine shortage problems, and even held meetings on cold medicine shortages, so a regular consultation system was created.
2023~2024: Shortage problems kept repeating
Supply instability continued for children's medicines, cough and phlegm medicines, enteral nutrition products, bronchodilators, and more, and the trend of checking seasonal risk items in advance became stronger.
2024: The response expands from 'meetings' to a 'system'
Drug price adjustments, administrative support, guidance on alternative medicines, AI-based shortage forecasts, management of reports on production, import, and supply stoppages, and even production support projects appeared.
2026: This syringe hotline
So this measure is not just a simple phone network. It can be seen as an extension of the way the government tries to hold the weak points of the supply chain in real time to prevent gaps in essential treatment.
So is this hotline a temporary fix, or a starting signal?
It is both. Right in front of us, it is clearly a temporary fix. The point is to give priority syringe supply to clinic-level dialysis centers until the end of June and prevent treatment gaps right away. But in a bigger view, this is also a signal that the Korean government has changed the way it handles the medical supply chain.
In the past, when a shortage happened, it often ended with asking the industry for cooperation. Now the tools are getting wider, including hotlines, public-private consultative groups, public supply, stockpiling, AI forecasting, and production support. In other words, it is moving from 'endure when a shortage happens' to 'manage items that are likely to face shortages in advance.'
This is also why this news matters for people living in Korea. Things we naturally use at hospitals, like syringes, IV fluids, and cold medicine, are not problems that can be solved only inside the hospital. War, shipping, raw materials, policy, and the structure of local clinics are all connected. This hotline is closer to a moment showing that the government has finally started looking at this complex connection not only in the language of 'medical care' but in the language of the supply chain.
This measure is not simply about getting more syringes. It is closer to a declaration that essential treatment will be managed from a supply chain point of view.
It especially shows that if local clinics in charge of repeated treatment become unstable, the burden on the whole medical system grows.
We will tell you how to live in Korea
Please give a lot of love to gltr life